Galapagos NV (Galapagos NV) Cash Flow for Lease Financing : $0.0 Mil (TTM As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Galapagos NV Cash Flow for Lease Financing?

Galapagos NV's Cash Flow for Lease Financing for the three months ended in Dec. 2023 was $0.0 Mil. Galapagos NV's Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Dec. 2023 was $0.0 Mil.

Compared with last quarter ($0.0 Mil in Sep. 2023 ), Galapagos NV's Cash Flow for Lease Financing remained the same in Dec. 2023 ($0.0 Mil).

Galapagos NV Cash Flow for Lease Financing Historical Data

The historical data trend for Galapagos NV's Cash Flow for Lease Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Galapagos NV Cash Flow for Lease Financing Chart

Galapagos NV Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash Flow for Lease Financing

Get a 7-Day Free Trial

Galapagos NV Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Cash Flow for Lease Financing	Get a 7-Day Free Trial															-	-	-	-	-

Galapagos NV Cash Flow for Lease Financing Calculation

Cash Flow for Lease Financing is change in cash flow resulting from increase or decrease in lease financing.

Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.0 Mil.

Galapagos NV Cash Flow for Lease Financing Related Terms

Thank you for viewing the detailed overview of Galapagos NV's Cash Flow for Lease Financing provided by GuruFocus.com. Please click on the following links to see related term pages.

Galapagos NV (Galapagos NV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Galapagos NV (NAS:GLPG) » Definitions » Cash Flow for Lease Financing

Comparable Companies

Traded in Other Exchanges

GLPG:Netherlands GLPG:Mexico 0JXZ:UK GXE:Germany G1LP34:Brazil GLPG:Austria

Address

Generaal De Wittelaan L11 A3, Mechelen, BEL, 2800

Website

https://www.glpg.com

Galapagos NV is a clinical-stage biotechnology company, involved in the discovery and development of small-molecule medicines. The company's product candidate portfolio includes Filgotinib, a JAK1 inhibitor to treat rheumatoid arthritis, Crohn's disease, and ulcerative colitis; novel therapies in cystic fibrosis (a chronic disease that affects the lungs and digestive system); GLPG1690, a selective autotaxin inhibitor with potential application in idiopathic pulmonary disease; GLPG1972 to treat osteoarthritis; and MOR106 to treat atopic dermatitis.